Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents by Bovy, P.R., Tjoeng, F.S., Rico, J.G., Rogers, T.E., Lindmark, R.J., Zablocki, J.A., Garland, R.B., McMackins, D.E., Dayringer, H., Tóth, M.V., Zupec, M.E., Rao, S., Panzer-Knodle, S.G., Nicholson, N.S., Salyers, A., Taite, B.B., Herin, M., Miyano, M., Feigen, L.P., Adams, S.P.

Get full text